secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACTUATE THERAPEUTICS, INC. (ACTU)
CIK:        0001652935
Form:       8-K
Filed at:   2025-09-10T23:59:59+00:00
Accession:  0001683168-25-006831
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Actuate Therapeutics prices $15M public offering of 2.14M shares at $7.00/share
-------------------------------------------------------------------------------

- Offers 2,142,858 shares at $7.00/share; gross proceeds ~$15M before discounts and expenses.
- Underwriters granted 30-day over-allotment option for up to 321,428 additional shares.
- Closing expected September 11, 2025; proceeds for working capital and general corporate purposes.
- Directors and executive officers subject to lock-up until December 9, 2025.
- Lucid Capital Markets sole book-runner; Titan Partners Group as financial advisor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1652935/000168316825006831/0001683168-25-006831-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1652935/000168316825006831/actuate_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-006831

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer